Zimmer Biomet Holdings, Inc. (ZBH), a medical technology company, Tuesday announced that it expects to repurchase up to $1 billion of its common stock during fiscal year 2026, a $250 million increase from the company's prior assumption.
"All repurchases are expected to be made under the company's existing $1.5 billion share repurchase authorization, which was approved by the Zimmer Biomet Board of Directors and announced in February 2026.", the med-tech company said on a statement.
In pre-market activity, ZBH shares were trading at $80.28, up 0.87% on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.